SAAD KHAN: Open Payments
NPI 1831541796 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 17 payments from 7 companies in 2025. Trend: 2023 $339 · 2024 $1,660 · 2025 $941
Food & beverage: $941
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $245 |
| Janssen Pharmaceuticals, Inc | 5 | $160 |
| Neurocrine BioSciences, Inc. | 1 | $132 |
| Alkermes, Inc. | 1 | $130 |
| ABBVIE INC. | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: Auvelity, SPRAVATO, INGREZZA, LYBALVI, VRAYLAR, FANAPT.
Industry payments across IL — which companies pay providers there.
